Imprimed

Series-A
imprimedicine.com Biotech & Healthcare United States
Total Funding Undisclosed
Latest Round Undisclosed Series-A
Last Announced Undisclosed
Investors 11 Backers
Decision Makers 5 Verified

About Imprimed

ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters United States
Tracked Since Sep 28, 2026

Web & Domain Identity

Official Website imprimedicine.com
Domain Registered Date Jan 30, 2016

Social & Network Presence

X / Twitter Profile @Imprimedicine (55 followers) Created on Nov 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Milestone

    X account created (@Imprimedicine)

    55 followers

  2. Milestone

    Website domain registered

    imprimedicine.com

Investors & Backers

11
Alois Ventures
BonAngels Venture Partners
Han River Partners
LB Investment
Mayo Clinic
Murex Partners
NAVER D2SF
Pear VC
Plug and Play
Samsung Securities
SBVA

Funding History

1 Round
Venture Round · Undisclosed
Undisclosed Source

Founders & Leadership

4

Hye Ryeon Lee

Founder

Work email & phone locked Unlock →

Jamin Koo

Founder

Work email & phone locked Unlock →

Sungwon Lim

Founder

Work email & phone locked Unlock →

Valerie Goodwin-Adams

Chief Commercial Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts